PAXIL is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp. The primary component is Paroxetine Hydrochloride Hemihydrate.
Product ID | 60505-3665_54b00e91-a925-b675-ad24-62ef9c87a452 |
NDC | 60505-3665 |
Product Type | Human Prescription Drug |
Proprietary Name | PAXIL |
Generic Name | Paroxetine Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2011-01-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020031 |
Labeler Name | Apotex Corp |
Substance Name | PAROXETINE HYDROCHLORIDE HEMIHYDRATE |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2011-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020031 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-01-01 |
Marketing End Date | 2020-10-31 |
Ingredient | Strength |
---|---|
PAROXETINE HYDROCHLORIDE HEMIHYDRATE | 30 mg/1 |
SPL SET ID: | 584ace29-6e40-432f-950f-ab7e98653d32 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
21695-159 | PAXIL | paroxetine hydrochloride |
21695-160 | PAXIL | paroxetine hydrochloride |
60505-4519 | PAXIL | PAXIL |
60505-4517 | PAXIL | PAXIL |
60505-4520 | PAXIL | PAXIL |
60505-3665 | PAXIL | PAXIL |
60505-0402 | PAXIL | PAXIL |
60505-3664 | PAXIL | PAXIL |
60505-3666 | PAXIL | PAXIL |
60505-3663 | PAXIL | PAXIL |
60505-4518 | PAXIL | PAXIL |
70518-2500 | PAXIL | PAXIL |
70518-2636 | PAXIL | PAXIL |
0904-5676 | PAROXETINE | paroxetine hydrochloride |
0904-5677 | PAROXETINE | paroxetine hydrochloride |
0904-5678 | PAROXETINE | paroxetine hydrochloride |
0904-5679 | PAROXETINE | paroxetine hydrochloride |
10544-433 | PAROXETINE | paroxetine hydrochloride |
10544-809 | PAROXETINE | paroxetine hydrochloride |
12634-248 | PAROXETINE | paroxetine hydrochloride |
16714-181 | Paroxetine | Paroxetine Hydrochloride |
16714-182 | Paroxetine | Paroxetine Hydrochloride |
16714-183 | Paroxetine | Paroxetine Hydrochloride |
16714-184 | Paroxetine | Paroxetine Hydrochloride |
21695-101 | Paroxetine | Paroxetine Hydrochloride |
21695-102 | Paroxetine | Paroxetine Hydrochloride |
21695-103 | Paroxetine | Paroxetine Hydrochloride |
21695-104 | Paroxetine | Paroxetine Hydrochloride |
43353-845 | Paroxetine | Paroxetine Hydrochloride |
0378-2003 | Paroxetine Hydrochloride | paroxetine hydrochloride |
0378-2004 | Paroxetine Hydrochloride | paroxetine hydrochloride |
0378-2005 | Paroxetine Hydrochloride | paroxetine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PAXIL 75284309 2220043 Live/Registered |
GLAXOSMITHKLINE LLC 1997-04-30 |
PAXIL 75282874 2220037 Live/Registered |
GLAXOSMITHKLINE LLC 1997-04-30 |
PAXIL 75180864 not registered Dead/Abandoned |
SmithKline Beecham Corporation 1996-10-15 |
PAXIL 75180863 not registered Dead/Abandoned |
SmithKline Beecham Corporation 1996-10-15 |
PAXIL 75169719 2219909 Live/Registered |
GLAXOSMITHKLINE LLC 1996-09-20 |
PAXIL 75169698 2166898 Dead/Cancelled |
SmithKline Beecham Corporation 1996-09-20 |
PAXIL 75169697 2219908 Live/Registered |
GLAXOSMITHKLINE LLC 1996-09-20 |
PAXIL 75169675 2144154 Live/Registered |
GLAXOSMITHKLINE LLC 1996-09-20 |
PAXIL 74184442 1821952 Live/Registered |
GLAXOSMITHKLINE LLC 1991-07-12 |
PAXIL 73255881 1170889 Dead/Cancelled |
Boehringer Ingelheim G.m.b.H. 1980-03-28 |